Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Utilization of a liver allograft from a hepatitis B surface antigen positive donor.

Transplantation - 15 Jan 2006

Ho Jin Kee, Harrigan P Richard, Sherlock Christopher H, Steinbrecher Urs P, Erb Siegfried R, Mo Theresa, Chung Stephen W, Buczkowski Andrezj K, Intaraprasong Pongphob, Scudamore Charles H, Yoshida Eric M

Abstract excerpt

With today's donor organ shortage, enhanced efforts must be made to utilize organs that previously would have been declined. We report a 26-year-old man with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) coinfection who received a liver transplant from an HBsAg-positive donor. HBV viremia (6,281,185 copies/ml) was seen early posttransplant despite lamivudine prophylaxis, but became negative with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cadaver
Share to Hepatitis B

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hepatitis B Surface Antigens

Share to Hepatitis B virus

Share to Hepatitis C

Share to Liver Transplantation

Share to Tissue Donors

Share to Transplantation, Homologous

Source

Identifiers

PMID: 16421489
DOI: 10.1097/01.tp.0000191946.49884.40

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Utilization of a liver allograft from a hepatitis B surface antigen positive donor.PMID 16421489Read ↗

Use of a hepatitis C virus (HCV) RNA-positive donor in a treated HCV RNA-negative liver transplant recipient.Semantic proximity Read ↗

Antiviral treatment with sofosbuvir and simeprevir in a kidney transplant recipient with HCV-decompensated cirrhosis: viral eradication and removal from the liver transplant waiting list.Semantic proximity Read ↗

Failure of hepatitis B surface antibody to protect acute fulminating hepatitis in a renal transplant recipient.Semantic proximity Read ↗

Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts.Semantic proximity Read ↗

Outcomes of hepatitis C- and hepatitis B core antibody-positive grafts in orthotopic liver transplantation.Semantic proximity Read ↗

Treatment of hepatitis C in potential lung transplant candidates.Semantic proximity Read ↗

Management of hepatitis B virus infection in liver transplant recipients: prospects and challenges.Semantic proximity Read ↗

Long-term outcome of hepatitis C virus infection after liver transplantation.Semantic proximity Read ↗

The use of hepatitis C-infected grafts in liver transplantation.Semantic proximity Read ↗

Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.Semantic proximity Read ↗

Utilization of hepatitis C antibody-positive livers: genotype dominance is virally determined.Semantic proximity Read ↗

Liver transplantation for hepatitis C-associated cirrhosis in a single Australian centre: referral patterns and transplant outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.